• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

常规免疫接种的恢复:绘制实现零剂次儿童接种的外部融资机会图谱。

Recovery of Routine Immunisation: Mapping External Financing Opportunities for Reaching Zero-Dose Children.

作者信息

Tougher Sarah, Mandalia Nikhil, Kou Griffiths Ulla

机构信息

Independent Researcher, Winnipeg, MB R3N 1P6, Canada.

United Nations Children's Fund (UNICEF) Programme Group, New York, NY 10017, USA.

出版信息

Vaccines (Basel). 2023 Jun 26;11(7):1159. doi: 10.3390/vaccines11071159.

DOI:10.3390/vaccines11071159
PMID:37514975
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10383242/
Abstract

The COVID-19 pandemic has precipitated large declines in childhood vaccination coverage and, consequently, substantial increases in the number of zero-dose children. To effectively respond to these declines, it is necessary to direct resources for recovery. We mapped active external financing for immunisation and primary healthcare in 20 countries with the highest numbers of zero-dose children to promote transparency and donor coordination. We found that countries have disparate access to external financing, with the two upper-middle-income countries (Brazil and Mexico) only having access to loans from the International Bank for Reconstruction and Development. Domestic resource mobilization is, therefore, key in these two countries, although fiscal space is likely constrained. Four additional countries (Angola, Indonesia, Philippines, and Vietnam) do not have allocations from Gavi, the Vaccine Alliance for Health Systems Strengthening, or Equity Accelerator Funding, but are eligible for support under Gavi's Middle-Income Countries Approach. Our methods, which focus on current donor financing, are novel and reveal substantial variations in access to external financing to support immunisation in high-burden countries. The available data differ considerably across financing mechanisms, making it difficult to synthesise the results across funding sources.

摘要

新冠疫情导致儿童疫苗接种覆盖率大幅下降,因此零剂次儿童数量大幅增加。为有效应对这些下降情况,有必要将资源用于恢复工作。我们绘制了零剂次儿童数量最多的20个国家的免疫和初级卫生保健外部资金流向图,以提高透明度并促进捐助方协调。我们发现,各国获得外部资金的机会各不相同,两个上中等收入国家(巴西和墨西哥)只能获得国际复兴开发银行的贷款。因此,在这两个国家,国内资源调动至关重要,尽管财政空间可能受到限制。另外四个国家(安哥拉、印度尼西亚、菲律宾和越南)没有获得疫苗免疫全球联盟(Gavi)用于加强卫生系统的拨款或公平加速基金,但有资格根据Gavi的中等收入国家方案获得支持。我们关注当前捐助资金的方法具有创新性,揭示了高负担国家在获得外部资金以支持免疫方面存在的巨大差异。不同融资机制的现有数据差异很大,难以综合不同资金来源的结果。

相似文献

1
Recovery of Routine Immunisation: Mapping External Financing Opportunities for Reaching Zero-Dose Children.常规免疫接种的恢复:绘制实现零剂次儿童接种的外部融资机会图谱。
Vaccines (Basel). 2023 Jun 26;11(7):1159. doi: 10.3390/vaccines11071159.
2
Sustainability of National Immunization Programme (NIP) performance and financing following Global Alliance for Vaccines and Immunization (GAVI) support to the Democratic Republic of the Congo (DRC).全球疫苗免疫联盟(GAVI)支持刚果民主共和国(DRC)后,国家免疫规划(NIP)绩效和融资的可持续性。
Vaccine. 2013 Apr 8;31(15):1886-91. doi: 10.1016/j.vaccine.2013.02.024. Epub 2013 Feb 24.
3
Gavi's Transition Policy: Moving From Development Assistance To Domestic Financing Of Immunization Programs.全球疫苗免疫联盟的过渡政策:从免疫计划的发展援助转向国内融资
Health Aff (Millwood). 2016 Feb;35(2):250-8. doi: 10.1377/hlthaff.2015.1079.
4
Effect of donor funding for immunization from Gavi and other development assistance channels on vaccine coverage: Evidence from 120 low and middle income recipient countries.高维助力和其他发展援助渠道对免疫接种的捐赠资金对疫苗接种覆盖率的影响:来自 120 个中低收入受援国的证据。
Vaccine. 2020 Jan 16;38(3):588-596. doi: 10.1016/j.vaccine.2019.10.057. Epub 2019 Nov 1.
5
Tracking donor funding towards achieving the Global Vaccine Action Plan (GVAP) goals: A landscape analysis (1990-2016).追踪实现全球疫苗行动计划(GVAP)目标的捐赠资金:景观分析(1990-2016 年)。
Vaccine. 2018 Nov 26;36(49):7487-7495. doi: 10.1016/j.vaccine.2018.10.062. Epub 2018 Oct 23.
6
Sustainable financing for Immunization Agenda 2030.免疫议程 2030 的可持续融资。
Vaccine. 2024 Apr 8;42 Suppl 1:S73-S81. doi: 10.1016/j.vaccine.2022.11.037. Epub 2022 Dec 2.
7
Has Gavi lived up to its promise? Quasi-experimental evidence on country immunisation rates and child mortality.全球疫苗免疫联盟是否兑现了承诺?关于国家免疫接种率和儿童死亡率的准实验证据。
BMJ Glob Health. 2019 Dec 3;4(6):e001789. doi: 10.1136/bmjgh-2019-001789. eCollection 2019.
8
Costs of vaccine programs across 94 low- and middle-income countries.94个低收入和中等收入国家的疫苗计划成本。
Vaccine. 2015 May 7;33 Suppl 1:A99-108. doi: 10.1016/j.vaccine.2014.12.037.
9
Pro-equity immunization and health systems strengthening strategies in select Gavi-supported countries.选择的获得免疫全球联盟支持的国家中的公平免疫和卫生系统加强战略。
Vaccine. 2021 Apr 22;39(17):2434-2444. doi: 10.1016/j.vaccine.2021.03.044. Epub 2021 Mar 27.
10
Public and private donor financing for health in developing countries.发展中国家卫生领域的公共和私人捐助资金。
Infect Dis Clin North Am. 1991 Jun;5(2):221-34.

本文引用的文献

1
Financing And Funding Gap For 16 Vaccines Across 94 Low- And Middle-Income Countries, 2011-30.2011 - 2030年94个低收入和中等收入国家16种疫苗的融资与资金缺口
Health Aff (Millwood). 2023 Jan;42(1):94-104. doi: 10.1377/hlthaff.2022.00343.
2
Estimating total spending by source of funding on routine and supplementary immunisation activities in low-income and middle-income countries, 2000-17: a financial modelling study.估算 2000-2017 年低收入和中等收入国家常规和补充免疫活动的资金来源总支出:一项金融模型研究。
Lancet. 2021 Nov 20;398(10314):1875-1893. doi: 10.1016/S0140-6736(21)01591-9. Epub 2021 Nov 4.
3
Tracking donor funding towards achieving the Global Vaccine Action Plan (GVAP) goals: A landscape analysis (1990-2016).追踪实现全球疫苗行动计划(GVAP)目标的捐赠资金:景观分析(1990-2016 年)。
Vaccine. 2018 Nov 26;36(49):7487-7495. doi: 10.1016/j.vaccine.2018.10.062. Epub 2018 Oct 23.
4
Tracking aid for global health goals: a systematic comparison of four approaches applied to reproductive, maternal, newborn, and child health.全球卫生目标追踪辅助工具:四种方法在生殖、孕产妇、新生儿和儿童健康方面的系统比较。
Lancet Glob Health. 2018 Aug;6(8):e859-e874. doi: 10.1016/S2214-109X(18)30276-6.